Skip to Content
Emily R. Winslow, MD

Contact Dr. Winslow

E-mail:
winslow@surgery.wisc.edu

Phone:
(608) 265-0500

Mail:
600 Highland Avenue
BX7375 CLINICAL SCIENCE CNTR
Madison, WI 53792-7375

Emily R. Winslow, MD

Assistant Professor
Section of Surgical Oncology
Division of General Surgery

Education

  • MD, Harvard Medical School, Boston, MA, 1999
  • Residency in Internal Medicine, Boston University School of Medicine, Boston, MA, 2000
  • Residency in General Surgery, Washington University School of Medicine, St. Louis, MO, 2000-2006
  • Fellowship in Hepatopancreaticobiliary Surgery, Washington University School of Medicine, St. Louis, MO, 2007
  • Fellowship in Transplant Surgery, Northwestern Memorial Hospital, Chicago, IL, 2009

Clinical Specialties

Dr. Winslow specializes in benign and malignant disease in the liver, bile duct, and pancreas. She performs both laparoscopic and open liver and pancreas surgery. She has specific clinical interest in patients with pancreatic cancer, cholangiocarcinoma, metatstatic colorectal cancer, and bile duct injuries. She is certified by the American Board of Surgery.

Dr. Winslow provides a wide range of services including Beger Procedure, Bile Duct Resection, Caudate Resection, Cryoablation, Cyst Fenestration (Unroof Liver Cyst), Frey Procedure, Gastrectomy - Partial or Total, Hemihepatectomy (Hepatectomy), Laparoscopic Gastrectomy, Laparoscopic Liver Resection, Laparoscopic Pancreatectomy, Liver Resection, Liver Tumor Ablations, Obstructed Pancreatic Duct Drainage (Peustow Procedure), Pancreatic Head Resection, Pancreaticoduodenectomy, Pancreatic Pseudocysts Drainage, Pancreatic Resections, Radical Cholecystectomy, Radiofrequency Ablation, (show all).

Research Interests

Dr. Winslow conducts clinical research in patients with pancreatic cancer and neuroendocrine tumors. She also is interested in outcomes studies in patients with hepatobiliary malignancies. She is currently pursuing a master’s degree in Clinical Investigation at the Institute for Clinical and Translational Research, with the goal of developing a data-based approach to early detection of pancreas cancer and the necessary screening tools for high risk groups.

Recent Publications
  • Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection.
    Cannon RM, LeGrand R, Chagpar RB, Ahmad SA, McClaine R, Kim HJ, Rupp C, Cho CS, Brinkman A, Weber S, Winslow ER, Kooby DA, Chu CK, Staley CA, Glenn I, Hawkins WG, Parikh AA, Merchant NB, McMasters KM, Martin RC, Callender GG, Scoggins CR
    HPB (Oxford) 2012 Apr; 14(4):228-35.
    [PubMed ID: 22404260]
    More Information
  • Ex vivo sentinel lymph node mapping in laparoscopic resection of colon cancer.
    Rivet EB, Mutch MG, Ritter JH, Khan AA, Lewis JS, Winslow E, Fleshman JW
    Colorectal Dis 2011 Nov; 13(11):1249-55.
    [PubMed ID: 21083799]
    More Information
  • Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis.
    Maithel SK, Kneuertz PJ, Kooby DA, Scoggins CR, Weber SM, Martin RC, McMasters KM, Cho CS, Winslow ER, Wood WC, Staley CA
    J. Am. Coll. Surg. 2011 Apr; 212(4):638-48; discussion 648-50.
    [PubMed ID: 21463803]
    More Information
  • Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy.
    Greenblatt DY, Kelly KJ, Rajamanickam V, Wan Y, Hanson T, Rettammel R, Winslow ER, Cho CS, Weber SM
    Ann. Surg. Oncol. 2011 Aug; 18(8):2126-35.
    [PubMed ID: 21336514]
    More Information
  • Risk stratification for distal pancreatectomy utilizing ACS-NSQIP: preoperative factors predict morbidity and mortality.
    Kelly KJ, Greenblatt DY, Wan Y, Rettammel RJ, Winslow E, Cho CS, Weber SM
    J. Gastrointest. Surg. 2011 Feb; 15(2):250-9, discussion 259-61.
    [PubMed ID: 21161427]
    More Information

webmaster@surgery.wisc.edu Copyright © 2012 The Board of Regents of the University of Wisconsin System